A detailed history of American International Group, Inc. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 46,686 shares of RLAY stock, worth $302,058. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,686
Previous 44,876 4.03%
Holding current value
$302,058
Previous $494,000 21.66%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$7.5 - $12.07 $13,575 - $21,846
1,810 Added 4.03%
46,686 $387,000
Q4 2023

Feb 13, 2024

SELL
$6.01 - $11.48 $1,087 - $2,077
-181 Reduced 0.4%
44,876 $494,000
Q3 2023

Nov 13, 2023

BUY
$8.24 - $12.97 $13,200 - $20,777
1,602 Added 3.69%
45,057 $378,000
Q2 2023

Aug 04, 2023

BUY
$9.99 - $18.27 $23,716 - $43,372
2,374 Added 5.78%
43,455 $545,000
Q1 2023

May 12, 2023

BUY
$15.0 - $22.76 $12,270 - $18,617
818 Added 2.03%
41,081 $676,000
Q4 2022

Feb 10, 2023

BUY
$14.16 - $24.02 $55,847 - $94,734
3,944 Added 10.86%
40,263 $601,000
Q3 2022

Nov 14, 2022

BUY
$18.07 - $31.37 $9,251 - $16,061
512 Added 1.43%
36,319 $812,000
Q2 2022

Aug 12, 2022

BUY
$13.31 - $34.88 $14,228 - $37,286
1,069 Added 3.08%
35,807 $600,000
Q1 2022

May 13, 2022

SELL
$20.26 - $32.36 $49,555 - $79,152
-2,446 Reduced 6.58%
34,738 $1.04 Million
Q4 2021

Feb 11, 2022

BUY
$26.0 - $37.03 $112,528 - $160,265
4,328 Added 13.17%
37,184 $1.14 Million
Q3 2021

Nov 12, 2021

BUY
$29.75 - $37.99 $1,576 - $2,013
53 Added 0.16%
32,856 $1.04 Million
Q2 2021

Aug 13, 2021

BUY
$27.5 - $38.19 $167,145 - $232,118
6,078 Added 22.74%
32,803 $1.2 Million
Q1 2021

May 07, 2021

BUY
$32.52 - $61.53 $260,680 - $493,224
8,016 Added 42.85%
26,725 $924,000
Q4 2020

Feb 12, 2021

SELL
$35.51 - $54.03 $19,033 - $28,960
-536 Reduced 2.79%
18,709 $778,000
Q3 2020

Nov 04, 2020

BUY
$32.81 - $45.1 $631,428 - $867,949
19,245 New
19,245 $820,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $778M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.